Alvotech Ordinary Shares (ALVO)
Alvotech Ordinary Shares (ALVO) is listed on Nasdaq, where it has traded since June 16, 2022.
- Listed On
- Nasdaq
- Listed Since
- June 16, 2022
- Employees
- 1,460
- Market Cap
- $2.1B
About Alvotech Ordinary Shares
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 69 institutions reported holding ALVO, with 42.5 million shares worth $157.4 million in aggregate. The largest reported holder was Rubric Capital Management, with 15.7 million shares worth $57.8 million. Of the 5 largest holders listed below, 1 opened a new position in ALVO and 4 added shares during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Rubric Capital Management | 15,677,093 | $58M | New position |
| Vanguard | 4,853,156 | $18M | Added 6.98% |
| Millennium Management | 4,263,644 | $16M | Added 100.87% |
| Bracebridge Capital | 4,038,637 | $15M | Added 49.29% |
| Farallon Capital Management | 2,859,675 | $11M | Added 1332.16% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is ALVO?
Alvotech Ordinary Shares (ALVO) is listed on Nasdaq, where it has traded since June 16, 2022.
Who are the largest institutional holders of ALVO?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of ALVO were Rubric Capital Management, Vanguard and Millennium Management.
How many institutions own ALVO?
69 institutions reported a position in ALVO for the quarter ended June 30, 2026, worth $157.4 million in total.
Did institutions buy or sell ALVO last quarter?
Of the 5 largest reported holders, 1 opened a new position in ALVO and 4 added shares during the quarter. Every reported holder and its change is on the SentiSense ownership page for ALVO.
Every reported institutional holder, plus insider and congressional trades in ALVO, on SentiSense.